RxDoctor Payments Data

Monica Dillard

Family · Alexandria, VANPI 1124469309

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 30.9% of the total. Reporting peaked in 2022 at $1,462 and has fallen 98.7% since, to $18 in 2025.

$2,996in general payments, 2019–2025

Across 155 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$926
  • Novo Nordisk$363
  • AstraZeneca$274
  • Lilly USA, LLC$264
  • Merck$179
  • Bayer$134
  • plus $857 from 23 others

What the payments were for

  • Food & beverage$2,996100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,996 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia →

Other family in Alexandria

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →